Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 GBX | -4.17% |
|
-14.81% | -75.53% |
06-14 | IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study | MT |
06-14 | IQ-AI team begins defining phase 2 protocol for oral gallium maltolate | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-75.53% | 3.38M | |
-17.74% | 8.18B | |
+68.25% | 4.32B | |
+5.67% | 2.74B | |
-2.98% | 2.62B | |
-51.24% | 1.95B | |
-19.04% | 1.67B | |
-22.51% | 1.41B | |
+16.69% | 1.2B | |
-44.81% | 1.12B |
- Stock Market
- Equities
- IQAI Stock
- News IQ-AI Limited
- IQ-AI's Imaging Biometrics Discloses Positive Results in Early-stage Study of Potential Brain Cancer Treatment